Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
8h agoDelivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
9h agoRefers to Item 7 on the agenda: Report on the audit of the consolidated financial statements of Grupa Kęty SA
11h agoThe 4th BOCHK Science and Technology Innovation Prize Award Ceremony Concludes with Great Success
18h agoBuffalo Potash Files Annual Information Form and New Technical Report
19h agoIonik Announces 30-Day Extension of Senior Debt Facility
Larimar Therapeutics, Inc. logo

Larimar Therapeutics, Inc.

About

3.45USD-0.12 -3.36%
Closed • Updated at 22:21 GMT+00:00
Market Cap$358.40M
Volume1.13M
Beta1.27
RSI34.95
Health TechnologyBiotechnology

Larimar Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 30 2026
Larimar Therapeutics Publishes Cross-Species Findings Supporting Skin as a Surrogate for the Measurement of Frataxin in Tissues Clinically Relevant to Friedreich’s Ataxia
Mar 19 2026
Larimar Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
Mar 4 2026
Larimar Therapeutics to Participate in Upcoming Investor Conferences in March
Feb 25 2026
Larimar Therapeutics Announces Proposed $75 Million Underwritten Public Offering
Feb 25 2026
Larimar Therapeutics Announces Pricing of Upsized $100 Million Underwritten Public Offering

Community Chat

Ask AI

Try asking
6ix6ixAIEvents